Please assess the completion status of the following clinical trial:

Trial Title: Clinical Trial Using the Proteolytic Fraction P1G10 From V. Cundinamarcensis to Heal Diabetic Foot Ulcer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical diagnosis of diabetes 2 had~* Hemoglobin ≥ 9.0 g/dl~* total leukocytes ≥ 300/ mm3~* platelets ≥ 100.00/mm3~* total bilirubin ≤ 1.0 mg/dL~* aspartate aminotransferase between 14 and 17 U/L in males and 10 and 33 U/L in females~* pyruvate transaminase between 10 and 40 U/L in males and 7 and 35 U/L in females~* creatinine between 0.70 and 1.20 mg/dL in males and 0.6 and 1.0 mg/dL in females~Exclusion criteria~* pregnant females~* lactating mothers~* highly exuding ulcers~* patients receiving alternative treatments for ulcers~* reported allergy to the components included in the formulation,~* concomitant uncontrolled morbidity~* current active infections,~* HIV serum positives~* diagnosed with neoplasia or undergoing treatment with a cytostatic, or immunosuppressing agent~* individuals subjected to radiotherapy within the last 3 months before beginning the trial.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Hydrogel treatment (Type: ACTIVE_COMPARATOR): It refers to the standard treatment currently applied for foot ulcers at the Health Center where the study was conducted. The intervention was applied to the cohort, three times a week during 16 weeks or when the wound attained full epithelization. The wound bed was cleaned with physiological serum before application of Hydrogel.
- P1G10 treatment (Type: EXPERIMENTAL): It refers to the experimental parallel intervention consisting of three weekly applications of 0.1% P1G10 dispersed in the hydrosoluble vehicle during a 16-week period, or until full epithelization of the wound. The wound bed was cleaned with physiological serum before application of the drug.

Based on this trial design, predict the completion outcome and termination type (if applicable).